Implication of Malignancy and Prognosis of p27 kip1 , Cyclin E, and Cdk2 Expression in Epithelial Ovarian Tumors

By Sui L.   Dong Y.   Ohno M.   Sugimoto K.   Tai Y.   Hando T.   Tokuda M.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 56-63

Elsevier

Access to resources Recommend Favorite

Expression and Subcellular Localization of the Cyclin-Dependent Kinase Inhibitor p27 Kip1 in Epithelial Ovarian Cancer

By Hurteau J.A.   Allison B.M.   Brutkiewicz S.A.   Goebl M.G.   Heilman D.K.   Bigsby R.M.   Harrington M.A.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 292-298

Elsevier

Access to resources Recommend Favorite

Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 (Kip1) in estrogen-related endometrial adenocarcinomas

By Torricelli Michela   Sanseverino Francesca  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 19-20

Informa Healthcare

Access to resources Recommend Favorite

miR222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1

By Sun Chaoyang   Li Na   Zhou Bo   Yang Zongyuan   Ding Dong   Weng Danhui   Meng Li   Wang Shixuan   Zhou Jianfeng   Ma Ding   Chen Gang  

Oncology Letters, Vol. 6, Iss. 2, 2013-08 ,pp. : 507-512

Spandidos Publications

Access to resources Recommend Favorite

Overexpression of Cyclin D1 in Epithelial Ovarian Cancers

By Worsley S.D.   Ponder B.A.J.   Davies B.R.  

Gynecologic Oncology, Vol. 64, Iss. 2, 1997-02 ,pp. : 189-195

Elsevier

Access to resources Recommend Favorite